Durvalumab (NSCLC): Solution concentrate for I.V. infusion 120 mg in 2.4 mL, Solution concentrate for I.V. infusion 500 mg in 10 mL; Imfinzi™
Page last updated: 1 November 2019
Page last updated: 1 November 2019
© Commonwealth of Australia
ABN: 83 605 426 759